Literature DB >> 24671952

Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation.

Michelle Rönnerblad1, Robin Andersson, Tor Olofsson, Iyadh Douagi, Mohsen Karimi, Sören Lehmann, Ilka Hoof, Michiel de Hoon, Masayoshi Itoh, Sayaka Nagao-Sato, Hideya Kawaji, Timo Lassmann, Piero Carninci, Yoshihide Hayashizaki, Alistair R R Forrest, Albin Sandelin, Karl Ekwall, Erik Arner, Andreas Lennartsson.   

Abstract

In development, epigenetic mechanisms such as DNA methylation have been suggested to provide a cellular memory to maintain multipotency but also stabilize cell fate decisions and direct lineage restriction. In this study, we set out to characterize changes in DNA methylation and gene expression during granulopoiesis using 4 distinct cell populations ranging from the oligopotent common myeloid progenitor stage to terminally differentiated neutrophils. We observed that differentially methylated sites (DMSs) generally show decreased methylation during granulopoiesis. Methylation appears to change at specific differentiation stages and overlap with changes in transcription and activity of key hematopoietic transcription factors. DMSs were preferentially located in areas distal to CpG islands and shores. Also, DMSs were overrepresented in enhancer elements and enriched in enhancers that become active during differentiation. Overall, this study depicts in detail the epigenetic and transcriptional changes that occur during granulopoiesis and supports the role of DNA methylation as a regulatory mechanism in blood cell differentiation.

Mesh:

Substances:

Year:  2014        PMID: 24671952     DOI: 10.1182/blood-2013-02-482893

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Integrative analysis of methylome and transcriptome in human blood identifies extensive sex- and immune cell-specific differentially methylated regions.

Authors:  Shimrat Mamrut; Nili Avidan; Elsebeth Staun-Ram; Elizabeta Ginzburg; Frederique Truffault; Sonia Berrih-Aknin; Ariel Miller
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

Review 2.  Epigenetic control of myeloid cell differentiation, identity and function.

Authors:  Damiana Álvarez-Errico; Roser Vento-Tormo; Michael Sieweke; Esteban Ballestar
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

3.  Changes in CpG methylation marks differentiation of human myeloid progenitors to neutrophils.

Authors:  Justin J L Wong; Jeff Holst
Journal:  Stem Cell Investig       Date:  2014-05-27

4.  Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism.

Authors:  Chew Leng Lim; Yu Zuan Or; Zoe Ong; Hwa Hwa Chung; Hirohito Hayashi; Smeeta Shrestha; Shunsuke Chiba; Feng Lin; Valerie Chun Ling Lin
Journal:  Elife       Date:  2020-07-24       Impact factor: 8.140

5.  Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes.

Authors:  Ying Qu; Andreas Lennartsson; Verena I Gaidzik; Stefan Deneberg; Mohsen Karimi; Sofia Bengtzén; Martin Höglund; Lars Bullinger; Konstanze Döhner; Sören Lehmann
Journal:  Epigenetics       Date:  2014-05-27       Impact factor: 4.528

6.  Rapid and specific hypomethylation of enhancers in endothelial cells during adaptation to cell culturing.

Authors:  Mia Magnusson; Pia Larsson; Emma Xuchun Lu; Niklas Bergh; Helena Carén; Sverker Jern
Journal:  Epigenetics       Date:  2016-06-14       Impact factor: 4.528

7.  Neutrophils in innate immunity and systems biology-level approaches.

Authors:  Viktoria Rungelrath; Scott D Kobayashi; Frank R DeLeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2019-06-20

Review 8.  Enhancer deregulation in cancer and other diseases.

Authors:  Hans-Martin Herz
Journal:  Bioessays       Date:  2016-08-29       Impact factor: 4.345

Review 9.  Enhancer DNA methylation in acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Leonidas Benetatos; George Vartholomatos
Journal:  Cell Mol Life Sci       Date:  2018-02-26       Impact factor: 9.261

10.  Transcriptional Control of Stem and Progenitor Potential.

Authors:  David E Muench; H Leighton Grimes
Journal:  Curr Stem Cell Rep       Date:  2015-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.